Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2023);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;%Female;Overton;SDG;Country;Region;Publisher;Coverage;Categories;Areas 1;21100853961;"ImmunoTargets and Therapy";journal;"22531556";2,140;Q1;25;14;63;768;498;62;6,56;54,86;40,35;0;12;New Zealand;Pacific Region;"Dove Medical Press Ltd.";"2015-2023";"Immunology (Q1); Immunology and Allergy (Q1)";"Immunology and Microbiology; Medicine" 2;19700175042;"Journal of Inflammation Research";journal;"11787031";1,047;Q2;51;456;1116;25917;4979;1105;4,25;56,84;42,68;0;185;New Zealand;Pacific Region;"Dove Medical Press Ltd.";"2010-2023";"Immunology (Q2); Immunology and Allergy (Q2)";"Immunology and Microbiology; Medicine" 3;19700171308;"Virology: Research and Treatment";journal;"1178122X";0,932;Q2;13;0;1;0;6;1;0,00;0,00;0,00;0;0;New Zealand;Pacific Region;"Libertas Academica Ltd.";"2010, 2013-2020";"Immunology (Q2); Infectious Diseases (Q2); Virology (Q2)";"Immunology and Microbiology; Medicine" 4;19700175786;"HIV/AIDS - Research and Palliative Care";journal;"11791373";0,527;Q3;32;64;253;2489;451;253;1,53;38,89;35,09;0;62;New Zealand;Pacific Region;"Dove Medical Press Ltd.";"2010-2023";"Dermatology (Q2); Health Policy (Q2); Epidemiology (Q3); Infectious Diseases (Q3); Virology (Q3)";"Immunology and Microbiology; Medicine"